1. EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib;RB Corcoran;Cancer Discov,2012
2. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer;AC Wolff;Arch Pathol Lab Med,2007
3. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version);ME Hammond;Arch Pathol Lab Med,2010
4. Hewitt S, Robinowitz M, Bogen S, Gown A, Kalra K, et al. (2011) Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays; Approved Guideline – Second Edition, CLSI Document I/LA28-A2. Wayne, Pennsylvania: Clinical and Laboratory Standards Institute.
5. The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma;IZ Yildiz-Aktas;Mod Pathol,2012